RFK Jr.'s peptide push could unleash risky drugs STAT First Opinion FDA to Consider Lifting Restrictions on Numerous Compounded Peptides Foley & Lardner Q&A: Should you trust trending peptide injections? Is BPC 157 Banned? Oral vs. Injectable Forms Explained In a major policy shift, the U.S. Food and Drug Administration is reconsidering restrictions on several controversial peptides, including trending compounds like BPC 157 and Melanotan II. The move comes as demand for The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York